In vitro-in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus (FK506) exposure.

about

In vitro-in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus (FK506) exposure.

Item

http://www.wikidata.org/entity/Q47760575

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

In vitro-in vivo extrapolation ...... n tacrolimus (FK506) exposure.

@en

In vitro-in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus

@nl

type

Item

label

In vitro-in vivo extrapolation ...... n tacrolimus (FK506) exposure.

@en

In vitro-in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus

@nl

prefLabel

In vitro-in vivo extrapolation ...... n tacrolimus (FK506) exposure.

@en

In vitro-in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus

@nl

P1476

In vitro-in vivo extrapolation ...... n tacrolimus (FK506) exposure.

@en

P2093

Katsuhiro Yamano

http://www.w3.org/2001/XMLSchema#string

Kazuo Oda

http://www.w3.org/2001/XMLSchema#string

Yukio Otsuka

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological Characterization, Structural Studies, and In Vivo Activities of Anti-Chagas Disease Lead Compounds Derived from Tipifarnib

Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4

The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions.

Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation

Interaction between FK506 and clotrimazole in a liver transplant recipient.

Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.

Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics.

The enzymatic basis of drug-drug interactions with systemic triazole antifungals.

Telaprevir: clinical pharmacokinetics, pharmacodynamics, and drug-drug interactions.

Beyond the ITC White Paper: emerging sciences in drug transporters and opportunities for drug development.

P304

265-274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BDD.1938

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25600613

http://www.w3.org/2001/XMLSchema#string